Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 975,583	$ 1,159,505	$ 4,655,863	$ 2,716,544
General and administrative	884,837	1,282,375	3,790,857	2,333,047
Total operating expenses	1,860,420	2,441,880	8,446,720	5,049,591
Loss from operations	(1,860,420)	(2,441,880)	(8,446,720)	(5,049,591)
Other income (expense):
Other income (expense)	25,734	(27,714)	(4,507)	(32,356)
Total other income (expense), net	25,734	(27,714)	(4,507)	(32,356)
Net loss	$ (1,834,686)	$ (2,469,594)	$ (8,451,227)	$ (5,081,947)
Net loss per share, basic	$ (0.12)	$ (0.39)	$ (0.58)	$ (1.61)
Net loss per share, diluted	$ (0.12)	$ (0.39)	$ (0.58)	$ (1.61)
Weighted-average shares used to compute net loss per share, basic	15,082,771	6,291,690	14,644,796	3,163,225
Weighted-average shares used to compute net loss per share, diluted	15,082,771	6,291,690	14,644,796	3,163,225